PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
02-Feb-2022 PrecisionLife announces first close of Series A financing to progress its drug discovery pipeline and commercial partnerships PrecisionLife
02-Feb-2022 Reaxys to enhance chemistry patents with patent provenance for greater competitive intelligence insights Elsevier
02-Feb-2022 Human Cell Design launches Endoc-BH5, an advanced human beta cell model enabling new discoveries in type 1 and 2 diabetes research Human Cell Design
01-Feb-2022 UK-made software to power millions of US lateral flow tests Bond Digital Health
31-Jan-2022 Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development AlivaMab Discovery Services
31-Jan-2022 LogiPharma leads the way as Tower takes cold chain containers on the road Tower Cold Chain
31-Jan-2022 Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector Scitara Corporation
31-Jan-2022 Tollys accelerates development of TLR3 agonist candidates for intravenous administration in immuno-oncology Andrew Lloyd Associates
30-Jan-2022 Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference SMi Group
29-Jan-2022 Registration is open for SMi’s 22nd Annual Pain Therapeutics Conference SMi Group
28-Jan-2022 3D Cell Culture Conference takes place in less than 2 weeks as a virtual conference SMi Group
28-Jan-2022 Investment in UK biotech jumps 60% to £4.5bn in 2021 BioIndustry Association (BIA) and Clarivate
27-Jan-2022 CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10M in the fifth call for Hospital-University Research in Health (RHU) projects Andrew Lloyd Associates
26-Jan-2022 Queen’s University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex Domainex
26-Jan-2022 Biological Discovery Company Launches New Product to Accelerate Target Discovery Synomics
26-Jan-2022 Immutep quarterly activities report and Appendix 4C Immutep
26-Jan-2022 Scottish bio-tech uFraction8 secures £2.5m commercialisation investment uFraction8
25-Jan-2022 Macomics Announces Five Additional Internationally Renowned Advisors with Immuno-oncology and Clinical Expertise Macomics
25-Jan-2022 FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy PTC Therapeutics
25-Jan-2022 Spartha Medical receives €2.4M in financing from European Innovation Council Andrew Lloyd Associates